MDS Latest News

EU drug approval for MDS sub-type del 5q

Great and long awaited positive news: Lenalidomide/Revlimid – the drug developed by pharma company Celgene has finally received approval for use in Europe – for transfusion dependent MDS patients who […]

Read full story

Rare Disease Day – 28th February

Rare Disease Day – 28th February Check what events took place all over the world: http://www.rarediseaseday.org/article/about-rare-disease-day Check also the video done for the occasion:   Lord Avebury – who often […]

Read full story

Newsletter 3 is online!

Our third Newsletter is now available online – with a update on clinical and research news from the ASH Congress (American Society of Haematology), from EHA (European Haematology Association), an […]

Read full story

Azacitidine research paper

Early research results about a better understanding of the way azacitidine works. Specifically about why azacitidine does not not in some people. This is encouraging, but very early research – […]

Read full story

MDS UK Newsletter Vol 2

Download our second newsletter containing updates, news from the American Society of Hematology 2011, introduction of our new patrons, fundraising stories, patient inputs and more.

Read full story
Free donations by shopping